Hilversum, Netherlands

Karin Van Charldorp

This inventor holds 1 USPTO granted patent. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karin Van Charldorp. Retrieved from https://idiyas.com/inventor/karin-van-charldorp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Karin Van Charldorp

Introduction

Karin Van Charldorp is a notable inventor based in Hilversum, Netherlands. She has made significant contributions to the field of pharmacology, particularly through her innovative work on 6-oxoazepinoindole compounds. Her research focuses on pharmacologically active compounds that have the potential to impact various medical applications.

Latest Patents

Karin holds one patent related to her work on 6-oxoazepinoindole compounds and pharmaceutical compositions containing these compounds. The patent details pharmacologically active compounds corresponding to a specific general formula, which includes various substituents that enhance their therapeutic potential.

Career Highlights

Karin is currently employed at Kali-Chemie Pharma GmbH, where she continues to advance her research in pharmaceutical chemistry. Her work is characterized by a commitment to developing innovative solutions that address unmet medical needs.

Collaborations

Karin has collaborated with esteemed colleagues such as Werner Benson and Peter C Gregory. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Karin Van Charldorp's contributions to pharmacology through her innovative patents and collaborative efforts highlight her role as a significant figure in the field. Her work continues to pave the way for advancements in pharmaceutical compositions and active compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…